What is Cogent Biosciences, Inc.'s restricted cash?

Cogent Biosciences, Inc. (COGT) reported restricted cash of $416K in Q1 2026.

What is the long-term trend for Cogent Biosciences, Inc.'s restricted cash?

Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s restricted cash has grown at a -19.8% compound annual growth rate (CAGR), from $1.26M to $416K.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Cogent Biosciences, Inc. COGT Restricted Cash

Restricted Cash at other companies

IncyteINCY

$1.84M+10.3%

Tango TherapeuticsTNGX

$0-100%

Scholar RockSRRK

$3.81M+58.2%

CRISPR TherapeuticsCRSP

$7.63M-4.7%

BridgeBio PharmaBBIO

——

Roivant SciencesROIV

——

Other financials

Income statement

See full

Operating income-$103.6M-38.3%

Net income-$97.4M-35.2%

EPS (diluted)-$0.53-1.9%

Balance sheet

See full

Cash & equivalents$241.2M+91.4%

Total debt$15.5M-9.4%

Total equity$607.7M+177%

Total assets$903.0M+218%

Cash flow

See full

Operating cash flow-$86.9M-30.6%

CapEx$449.0K-17.9%

Free cash flow-$87.3M-30.2%

Valuation

See full

Market cap$5.9B+816%

Enterprise value$5.68B+951%

P/S749.8×—

Profitability

See full

Operating margin-1,044.3%—

Net margin-950.4%—

FCF margin-184.7%—

Returns & leverage

See full

Return on equity-85.7%+1.7pp

Debt / equity0×-0.1×

Current ratio15.1×+10.0×

Where this comes from

Reported directly by Cogent Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s restricted cash?: Cogent Biosciences, Inc. (COGT) reported restricted cash of $416K in Q1 2026.
What is the long-term trend for Cogent Biosciences, Inc.'s restricted cash?: Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s restricted cash has grown at a -19.8% compound annual growth rate (CAGR), from $1.26M to $416K.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.